Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 06-2022 | 06-2021 | |
| Sales | 1,454 | 1,434 | 0 | 0 | 10,053 |
| Cost of Goods | N/A | N/A | N/A | N/A | 4,932 |
| Gross Profit | 1,454 | 1,434 | N/A | N/A | 5,121 |
| Operating Expenses | 92,340 | 42,375 | 0 | 6,419 | 9,499 |
| Operating Income | -90,886 | -40,941 | N/A | -6,419 | -3,446 |
| Interest Expense | 48 | 82 | 0 | 0 | 0 |
| Other Income | 10,507 | 917 | 0 | -853 | 59 |
| Pre-tax Income | -80,427 | -40,106 | 0 | -7,272 | -3,387 |
| Net Income Continuous | -80,427 | -40,106 | N/A | -7,272 | -3,387 |
| Net Income Discontinuous | -949 | -9,053 | N/A | N/A | N/A |
| Net Income Extraordinary | 2,097 | 2,651 | N/A | N/A | N/A |
| Net Income | $-79,279 | $-46,508 | $N/A | $-7,272 | $-3,387 |
| EPS Basic Total Ops | -1.23 | -1.74 | N/A | -0.50 | -0.30 |
| EPS Basic Continuous Ops | -1.22 | -1.40 | N/A | -0.40 | -0.33 |
| EPS Basic Discontinuous Ops | -0.01 | -0.34 | N/A | -0.10 | N/A |
| EPS Diluted Total Ops | -1.23 | -1.74 | N/A | -0.50 | -0.30 |
| EPS Diluted Continuous Ops | -1.22 | -1.40 | N/A | -0.40 | -0.33 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.34 | N/A | -0.10 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.85 | -1.40 | -0.50 | N/A | N/A |
| EBITDA(a) | $-65,125 | $-39,955 | $N/A | $-6,139 | $-3,229 |